SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-142950
Filing Date
2024-05-20
Accepted
2024-05-20 17:00:35
Documents
15
Period of Report
2024-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820823d8k.htm   iXBRL 8-K 26983
2 EX-10.1 d820823dex101.htm EX-10.1 281879
3 EX-99.1 d820823dex991.htm EX-99.1 27876
  Complete submission text file 0001193125-24-142950.txt   550377

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20240517.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20240517_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20240517_pre.xml EX-101.PRE 11725
18 EXTRACTED XBRL INSTANCE DOCUMENT d820823d8k_htm.xml XML 3768
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 24965501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)